APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasma Proteomics Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Plasma Proteomics Service Market Outlook and Growth Opportunities 2026

12 August 2026216 pages

Choose your research edition.

Industry ResearchPlasma Proteomics Service Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma Proteomics Service Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Plasma Proteomics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma Proteomics Service Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma Proteomics Service Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Plasma Proteomics Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasma Proteomics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Plasma Proteomics Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Plasma Proteomics Service market include BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, Cell Signaling Technology (CST) and Sampled (Infinity Biologix), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Plasma Proteomics Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Plasma Proteomics Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plasma Proteomics Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Plasma Proteomics Service market.

Plasma Proteomics Service Segment by Company

BostonGene

CellCarta

GENEWIZ (Azenta Life Sciences)

CDI Labs

Biognosys

Discovery Life Sciences

Firalis Molecular Precision

Cell Signaling Technology (CST)

Sampled (Infinity Biologix)

APTBIO

Sinotech Genomics

Biodesix

Panome Bio

Novogene

PTM BIO

BGI Genomics

Evotec

Metware Biotechnology

MRM Proteomics

Lc-Bio Technologies

Eurofins Scientific

MtoZ-Biolabs

Creative Proteomics

Macrogen

TATAA Biocenter

OmicScouts (Momentum Biotechnologies)

Precision Biomarker Laboratories (PBL)

Shanghai OE Biotech

RxCelerate

Proteomics International

Proteome Sciences

Westlake Omics

Crown Bioscience

VProteomics

Shanghai Majorbio Bio-Pharm

Applied Biomics

Sapient Bioanalytics

Allumiqs

MS Bioworks

Shanghai Bioprofile

Cosmos Wisdom

Olink (Thermo Fisher Scientific)

SomaLogic (Illumina)

Labcorp

Plasma Proteomics Service Segment by Type

Discovery Plasma Proteomics

DIA Plasma Proteomics

TMT Plasma Proteomics

Targeted Plasma Proteomics

Others

Plasma Proteomics Service Segment by Application

Disease Biomarker Research

Drug Development

Clinical Research

Others

Plasma Proteomics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Plasma Proteomics Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Plasma Proteomics Service key companies, revenue, market share, and recent developments.

3. To split the Plasma Proteomics Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Plasma Proteomics Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Plasma Proteomics Service significant trends, drivers, influence factors in global and regions.

6. To analyze Plasma Proteomics Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Proteomics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Proteomics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Proteomics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plasma Proteomics Service industry.

Chapter 3: Detailed analysis of Plasma Proteomics Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Plasma Proteomics Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Plasma Proteomics Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Plasma Proteomics Service Industry Trends Table 2. Plasma Proteomics Service Industry Drivers Table 3. Plasma Proteomics Service Industry Opportunities and Challenges Table 4. Plasma Proteomics Service Industry Restraints Table 5. Global Plasma Proteomics Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Plasma Proteomics Service Revenue Share by Company (2021-2026) Table 7. Global Plasma Proteomics Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Plasma Proteomics Service Key Company Manufacturing Base & Headquarters Table 9. Global Plasma Proteomics Service Company, Product Type & Application Table 10. Global Plasma Proteomics Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Plasma Proteomics Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Discovery Plasma Proteomics Table 15. Significant Companies of DIA Plasma Proteomics Table 16. Significant Companies of TMT Plasma Proteomics Table 17. Significant Companies of Targeted Plasma Proteomics Table 18. Significant Companies of Others Table 19. Global Plasma Proteomics Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Plasma Proteomics Service Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Plasma Proteomics Service Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Plasma Proteomics Service Sales Value Share by Type (2021-2026) Table 23. Global Plasma Proteomics Service Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Disease Biomarker Research Table 25. Significant Companies of Drug Development Table 26. Significant Companies of Clinical Research Table 27. Significant Companies of Others Table 28. Global Plasma Proteomics Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Plasma Proteomics Service Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Plasma Proteomics Service Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Plasma Proteomics Service Sales Value Share by Application (2021-2026) Table 32. Global Plasma Proteomics Service Sales Value Share by Application (2027-2032) Table 33. Global Plasma Proteomics Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Plasma Proteomics Service Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Plasma Proteomics Service Sales Value Share by Region (2021-2026) Table 36. Global Plasma Proteomics Service Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Plasma Proteomics Service Sales Value Share by Region (2027-2032) Table 38. Global Plasma Proteomics Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Plasma Proteomics Service Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Plasma Proteomics Service Sales Value Market Share by Country (2021-2026) Table 41. Global Plasma Proteomics Service Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Plasma Proteomics Service Sales Value Market Share by Country (2027-2032) Table 43. BostonGene Company Information Table 44. BostonGene Business Overview Table 45. BostonGene Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. BostonGene Plasma Proteomics Service Product Portfolio Table 47. BostonGene Recent Development Table 48. CellCarta Company Information Table 49. CellCarta Business Overview Table 50. CellCarta Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. CellCarta Plasma Proteomics Service Product Portfolio Table 52. CellCarta Recent Development Table 53. GENEWIZ (Azenta Life Sciences) Company Information Table 54. GENEWIZ (Azenta Life Sciences) Business Overview Table 55. GENEWIZ (Azenta Life Sciences) Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. GENEWIZ (Azenta Life Sciences) Plasma Proteomics Service Product Portfolio Table 57. GENEWIZ (Azenta Life Sciences) Recent Development Table 58. CDI Labs Company Information Table 59. CDI Labs Business Overview Table 60. CDI Labs Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. CDI Labs Plasma Proteomics Service Product Portfolio Table 62. CDI Labs Recent Development Table 63. Biognosys Company Information Table 64. Biognosys Business Overview Table 65. Biognosys Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Biognosys Plasma Proteomics Service Product Portfolio Table 67. Biognosys Recent Development Table 68. Discovery Life Sciences Company Information Table 69. Discovery Life Sciences Business Overview Table 70. Discovery Life Sciences Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Discovery Life Sciences Plasma Proteomics Service Product Portfolio Table 72. Discovery Life Sciences Recent Development Table 73. Firalis Molecular Precision Company Information Table 74. Firalis Molecular Precision Business Overview Table 75. Firalis Molecular Precision Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Firalis Molecular Precision Plasma Proteomics Service Product Portfolio Table 77. Firalis Molecular Precision Recent Development Table 78. Cell Signaling Technology (CST) Company Information Table 79. Cell Signaling Technology (CST) Business Overview Table 80. Cell Signaling Technology (CST) Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Cell Signaling Technology (CST) Plasma Proteomics Service Product Portfolio Table 82. Cell Signaling Technology (CST) Recent Development Table 83. Sampled (Infinity Biologix) Company Information Table 84. Sampled (Infinity Biologix) Business Overview Table 85. Sampled (Infinity Biologix) Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sampled (Infinity Biologix) Plasma Proteomics Service Product Portfolio Table 87. Sampled (Infinity Biologix) Recent Development Table 88. APTBIO Company Information Table 89. APTBIO Business Overview Table 90. APTBIO Plasma Proteomics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. APTBIO Plasma Proteomics Service Product Portfolio Table 92. APTBIO Recent Development Table 93. Sinotech Genomics Company Information Table 94. Sinotech Genomics Business Overview Table 95. Sinotech Genomics Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Sinotech Genomics Plasma Proteomics Service Product Portfolio Table 97. Sinotech Genomics Recent Development Table 98. Biodesix Company Information Table 99. Biodesix Business Overview Table 100. Biodesix Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Biodesix Plasma Proteomics Service Product Portfolio Table 102. Biodesix Recent Development Table 103. Panome Bio Company Information Table 104. Panome Bio Business Overview Table 105. Panome Bio Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Panome Bio Plasma Proteomics Service Product Portfolio Table 107. Panome Bio Recent Development Table 108. Novogene Company Information Table 109. Novogene Business Overview Table 110. Novogene Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Novogene Plasma Proteomics Service Product Portfolio Table 112. Novogene Recent Development Table 113. PTM BIO Company Information Table 114. PTM BIO Business Overview Table 115. PTM BIO Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. PTM BIO Plasma Proteomics Service Product Portfolio Table 117. PTM BIO Recent Development Table 118. BGI Genomics Company Information Table 119. BGI Genomics Business Overview Table 120. BGI Genomics Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. BGI Genomics Plasma Proteomics Service Product Portfolio Table 122. BGI Genomics Recent Development Table 123. Evotec Company Information Table 124. Evotec Business Overview Table 125. Evotec Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Evotec Plasma Proteomics Service Product Portfolio Table 127. Evotec Recent Development Table 128. Metware Biotechnology Company Information Table 129. Metware Biotechnology Business Overview Table 130. Metware Biotechnology Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Metware Biotechnology Plasma Proteomics Service Product Portfolio Table 132. Metware Biotechnology Recent Development Table 133. MRM Proteomics Company Information Table 134. MRM Proteomics Business Overview Table 135. MRM Proteomics Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. MRM Proteomics Plasma Proteomics Service Product Portfolio Table 137. MRM Proteomics Recent Development Table 138. Lc-Bio Technologies Company Information Table 139. Lc-Bio Technologies Business Overview Table 140. Lc-Bio Technologies Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Lc-Bio Technologies Plasma Proteomics Service Product Portfolio Table 142. Lc-Bio Technologies Recent Development Table 143. Eurofins Scientific Company Information Table 144. Eurofins Scientific Business Overview Table 145. Eurofins Scientific Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Eurofins Scientific Plasma Proteomics Service Product Portfolio Table 147. Eurofins Scientific Recent Development Table 148. MtoZ-Biolabs Company Information Table 149. MtoZ-Biolabs Business Overview Table 150. MtoZ-Biolabs Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. MtoZ-Biolabs Plasma Proteomics Service Product Portfolio Table 152. MtoZ-Biolabs Recent Development Table 153. Creative Proteomics Company Information Table 154. Creative Proteomics Business Overview Table 155. Creative Proteomics Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Creative Proteomics Plasma Proteomics Service Product Portfolio Table 157. Creative Proteomics Recent Development Table 158. Macrogen Company Information Table 159. Macrogen Business Overview Table 160. Macrogen Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. Macrogen Plasma Proteomics Service Product Portfolio Table 162. Macrogen Recent Development Table 163. TATAA Biocenter Company Information Table 164. TATAA Biocenter Business Overview Table 165. TATAA Biocenter Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. TATAA Biocenter Plasma Proteomics Service Product Portfolio Table 167. TATAA Biocenter Recent Development Table 168. OmicScouts (Momentum Biotechnologies) Company Information Table 169. OmicScouts (Momentum Biotechnologies) Business Overview Table 170. OmicScouts (Momentum Biotechnologies) Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 171. OmicScouts (Momentum Biotechnologies) Plasma Proteomics Service Product Portfolio Table 172. OmicScouts (Momentum Biotechnologies) Recent Development Table 173. Precision Biomarker Laboratories (PBL) Company Information Table 174. Precision Biomarker Laboratories (PBL) Business Overview Table 175. Precision Biomarker Laboratories (PBL) Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 176. Precision Biomarker Laboratories (PBL) Plasma Proteomics Service Product Portfolio Table 177. Precision Biomarker Laboratories (PBL) Recent Development Table 178. Shanghai OE Biotech Company Information Table 179. Shanghai OE Biotech Business Overview Table 180. Shanghai OE Biotech Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 181. Shanghai OE Biotech Plasma Proteomics Service Product Portfolio Table 182. Shanghai OE Biotech Recent Development Table 183. RxCelerate Company Information Table 184. RxCelerate Business Overview Table 185. RxCelerate Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 186. RxCelerate Plasma Proteomics Service Product Portfolio Table 187. RxCelerate Recent Development Table 188. Proteomics International Company Information Table 189. Proteomics International Business Overview Table 190. Proteomics International Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 191. Proteomics International Plasma Proteomics Service Product Portfolio Table 192. Proteomics International Recent Development Table 193. Proteome Sciences Company Information Table 194. Proteome Sciences Business Overview Table 195. Proteome Sciences Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 196. Proteome Sciences Plasma Proteomics Service Product Portfolio Table 197. Proteome Sciences Recent Development Table 198. Westlake Omics Company Information Table 199. Westlake Omics Business Overview Table 200. Westlake Omics Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 201. Westlake Omics Plasma Proteomics Service Product Portfolio Table 202. Westlake Omics Recent Development Table 203. Crown Bioscience Company Information Table 204. Crown Bioscience Business Overview Table 205. Crown Bioscience Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 206. Crown Bioscience Plasma Proteomics Service Product Portfolio Table 207. Crown Bioscience Recent Development Table 208. VProteomics Company Information Table 209. VProteomics Business Overview Table 210. VProteomics Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 211. VProteomics Plasma Proteomics Service Product Portfolio Table 212. VProteomics Recent Development Table 213. Shanghai Majorbio Bio-Pharm Company Information Table 214. Shanghai Majorbio Bio-Pharm Business Overview Table 215. Shanghai Majorbio Bio-Pharm Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 216. Shanghai Majorbio Bio-Pharm Plasma Proteomics Service Product Portfolio Table 217. Shanghai Majorbio Bio-Pharm Recent Development Table 218. Applied Biomics Company Information Table 219. Applied Biomics Business Overview Table 220. Applied Biomics Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 221. Applied Biomics Plasma Proteomics Service Product Portfolio Table 222. Applied Biomics Recent Development Table 223. Sapient Bioanalytics Company Information Table 224. Sapient Bioanalytics Business Overview Table 225. Sapient Bioanalytics Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 226. Sapient Bioanalytics Plasma Proteomics Service Product Portfolio Table 227. Sapient Bioanalytics Recent Development Table 228. Allumiqs Company Information Table 229. Allumiqs Business Overview Table 230. Allumiqs Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 231. Allumiqs Plasma Proteomics Service Product Portfolio Table 232. Allumiqs Recent Development Table 233. MS Bioworks Company Information Table 234. MS Bioworks Business Overview Table 235. MS Bioworks Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 236. MS Bioworks Plasma Proteomics Service Product Portfolio Table 237. MS Bioworks Recent Development Table 238. Shanghai Bioprofile Company Information Table 239. Shanghai Bioprofile Business Overview Table 240. Shanghai Bioprofile Plasma Proteomics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 241. Shanghai Bioprofile Plasma Proteomics Service Product Portfolio Table 242. Shanghai Bioprofile Recent Development Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Plasma Proteomics Service Product Image Figure 2. Global Plasma Proteomics Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma Proteomics Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasma Proteomics Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Discovery Plasma Proteomics Image Figure 8. DIA Plasma Proteomics Image Figure 9. TMT Plasma Proteomics Image Figure 10. Targeted Plasma Proteomics Image Figure 11. Others Image Figure 12. Global Plasma Proteomics Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Plasma Proteomics Service Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Plasma Proteomics Service Sales Value Share by Type (2021-2032) Figure 15. Disease Biomarker Research Image Figure 16. Drug Development Image Figure 17. Clinical Research Image Figure 18. Others Image Figure 19. Global Plasma Proteomics Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Plasma Proteomics Service Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Plasma Proteomics Service Sales Value Share by Application (2021-2032) Figure 22. Global Plasma Proteomics Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Plasma Proteomics Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Plasma Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 25. North America Plasma Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Plasma Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Plasma Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Plasma Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Plasma Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Plasma Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 31. South America Plasma Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Plasma Proteomics Service Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Plasma Proteomics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Plasma Proteomics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Discovery Plasma Proteomics
  • DIA Plasma Proteomics
  • TMT Plasma Proteomics
  • Targeted Plasma Proteomics
  • Others
Applications
  • Disease Biomarker Research
  • Drug Development
  • Clinical Research
  • Others
Companies covered
  • BostonGene
  • CellCarta
  • GENEWIZ (Azenta Life Sciences)
  • CDI Labs
  • Biognosys
  • Discovery Life Sciences
  • Firalis Molecular Precision
  • Cell Signaling Technology (CST)
  • Sampled (Infinity Biologix)
  • APTBIO
  • Sinotech Genomics
  • Biodesix
  • Panome Bio
  • Novogene
  • PTM BIO
  • BGI Genomics
  • Evotec
  • Metware Biotechnology
  • MRM Proteomics
  • Lc-Bio Technologies
  • Eurofins Scientific
  • MtoZ-Biolabs
  • Creative Proteomics
  • Macrogen
  • TATAA Biocenter
  • OmicScouts (Momentum Biotechnologies)
  • Precision Biomarker Laboratories (PBL)
  • Shanghai OE Biotech
  • RxCelerate
  • Proteomics International
  • Proteome Sciences
  • Westlake Omics
  • Crown Bioscience
  • VProteomics
  • Shanghai Majorbio Bio-Pharm
  • Applied Biomics
  • Sapient Bioanalytics
  • Allumiqs
  • MS Bioworks
  • Shanghai Bioprofile
  • Cosmos Wisdom
  • Olink (Thermo Fisher Scientific)
  • SomaLogic (Illumina)
  • Labcorp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Plasma Proteomics Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Plasma Proteomics Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Plasma Proteomics Service Market Dynamics
  1. 2.1 Plasma Proteomics Service Industry Trends
  2. 2.2 Plasma Proteomics Service Industry Drivers
  3. 2.3 Plasma Proteomics Service Industry Opportunities and Challenges
  4. 2.4 Plasma Proteomics Service Industry Restraints
3 Plasma Proteomics Service Market by Company
  1. 3.1 Global Plasma Proteomics Service Company Revenue Ranking in 2025
  2. 3.2 Global Plasma Proteomics Service Revenue by Company (2021-2026)
  3. 3.3 Global Plasma Proteomics Service Company Ranking (2024-2026)
  4. 3.4 Global Plasma Proteomics Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Plasma Proteomics Service Company Product Type and Application
  6. 3.6 Global Plasma Proteomics Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Plasma Proteomics Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Plasma Proteomics Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Plasma Proteomics Service Market by Type
  1. 4.1 Plasma Proteomics Service Type Introduction
  2. 4.1.1 Discovery Plasma Proteomics
  3. 4.1.2 DIA Plasma Proteomics
  4. 4.1.3 TMT Plasma Proteomics
  5. 4.1.4 Targeted Plasma Proteomics
  6. 4.1.5 Others
  7. 4.2 Global Plasma Proteomics Service Sales Value by Type
  8. 4.2.1 Global Plasma Proteomics Service Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Plasma Proteomics Service Sales Value by Type (2021-2032)
  10. 4.2.3 Global Plasma Proteomics Service Sales Value Share by Type (2021-2032)
5 Plasma Proteomics Service Market by Application
  1. 5.1 Plasma Proteomics Service Application Introduction
  2. 5.1.1 Disease Biomarker Research
  3. 5.1.2 Drug Development
  4. 5.1.3 Clinical Research
  5. 5.1.4 Others
  6. 5.2 Global Plasma Proteomics Service Sales Value by Application
  7. 5.2.1 Global Plasma Proteomics Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Plasma Proteomics Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Plasma Proteomics Service Sales Value Share by Application (2021-2032)
6 Plasma Proteomics Service Regional Value Analysis
  1. 6.1 Global Plasma Proteomics Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plasma Proteomics Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Plasma Proteomics Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Plasma Proteomics Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Plasma Proteomics Service Sales Value (2021-2032)
  7. 6.3.2 North America Plasma Proteomics Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Plasma Proteomics Service Sales Value (2021-2032)
  10. 6.4.2 Europe Plasma Proteomics Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Plasma Proteomics Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Plasma Proteomics Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Plasma Proteomics Service Sales Value (2021-2032)
  16. 6.6.2 South America Plasma Proteomics Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Plasma Proteomics Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Plasma Proteomics Service Sales Value Share by Country, 2025 VS 2032
7 Plasma Proteomics Service Country-level Value Analysis
  1. 7.1 Global Plasma Proteomics Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Plasma Proteomics Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Plasma Proteomics Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Plasma Proteomics Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Plasma Proteomics Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Plasma Proteomics Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Plasma Proteomics Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BostonGene
  2. 8.1.1 BostonGene Company Information
  3. 8.1.2 BostonGene Business Overview
  4. 8.1.3 BostonGene Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BostonGene Plasma Proteomics Service Product Portfolio
  6. 8.1.5 BostonGene Recent Developments
  7. 8.2 CellCarta
  8. 8.2.1 CellCarta Company Information
  9. 8.2.2 CellCarta Business Overview
  10. 8.2.3 CellCarta Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CellCarta Plasma Proteomics Service Product Portfolio
  12. 8.2.5 CellCarta Recent Developments
  13. 8.3 GENEWIZ (Azenta Life Sciences)
  14. 8.3.1 GENEWIZ (Azenta Life Sciences) Company Information
  15. 8.3.2 GENEWIZ (Azenta Life Sciences) Business Overview
  16. 8.3.3 GENEWIZ (Azenta Life Sciences) Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GENEWIZ (Azenta Life Sciences) Plasma Proteomics Service Product Portfolio
  18. 8.3.5 GENEWIZ (Azenta Life Sciences) Recent Developments
  19. 8.4 CDI Labs
  20. 8.4.1 CDI Labs Company Information
  21. 8.4.2 CDI Labs Business Overview
  22. 8.4.3 CDI Labs Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CDI Labs Plasma Proteomics Service Product Portfolio
  24. 8.4.5 CDI Labs Recent Developments
  25. 8.5 Biognosys
  26. 8.5.1 Biognosys Company Information
  27. 8.5.2 Biognosys Business Overview
  28. 8.5.3 Biognosys Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Biognosys Plasma Proteomics Service Product Portfolio
  30. 8.5.5 Biognosys Recent Developments
  31. 8.6 Discovery Life Sciences
  32. 8.6.1 Discovery Life Sciences Company Information
  33. 8.6.2 Discovery Life Sciences Business Overview
  34. 8.6.3 Discovery Life Sciences Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Discovery Life Sciences Plasma Proteomics Service Product Portfolio
  36. 8.6.5 Discovery Life Sciences Recent Developments
  37. 8.7 Firalis Molecular Precision
  38. 8.7.1 Firalis Molecular Precision Company Information
  39. 8.7.2 Firalis Molecular Precision Business Overview
  40. 8.7.3 Firalis Molecular Precision Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Firalis Molecular Precision Plasma Proteomics Service Product Portfolio
  42. 8.7.5 Firalis Molecular Precision Recent Developments
  43. 8.8 Cell Signaling Technology (CST)
  44. 8.8.1 Cell Signaling Technology (CST) Company Information
  45. 8.8.2 Cell Signaling Technology (CST) Business Overview
  46. 8.8.3 Cell Signaling Technology (CST) Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cell Signaling Technology (CST) Plasma Proteomics Service Product Portfolio
  48. 8.8.5 Cell Signaling Technology (CST) Recent Developments
  49. 8.9 Sampled (Infinity Biologix)
  50. 8.9.1 Sampled (Infinity Biologix) Company Information
  51. 8.9.2 Sampled (Infinity Biologix) Business Overview
  52. 8.9.3 Sampled (Infinity Biologix) Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sampled (Infinity Biologix) Plasma Proteomics Service Product Portfolio
  54. 8.9.5 Sampled (Infinity Biologix) Recent Developments
  55. 8.10 APTBIO
  56. 8.10.1 APTBIO Company Information
  57. 8.10.2 APTBIO Business Overview
  58. 8.10.3 APTBIO Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 APTBIO Plasma Proteomics Service Product Portfolio
  60. 8.10.5 APTBIO Recent Developments
  61. 8.11 Sinotech Genomics
  62. 8.11.1 Sinotech Genomics Company Information
  63. 8.11.2 Sinotech Genomics Business Overview
  64. 8.11.3 Sinotech Genomics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sinotech Genomics Plasma Proteomics Service Product Portfolio
  66. 8.11.5 Sinotech Genomics Recent Developments
  67. 8.12 Biodesix
  68. 8.12.1 Biodesix Company Information
  69. 8.12.2 Biodesix Business Overview
  70. 8.12.3 Biodesix Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Biodesix Plasma Proteomics Service Product Portfolio
  72. 8.12.5 Biodesix Recent Developments
  73. 8.13 Panome Bio
  74. 8.13.1 Panome Bio Company Information
  75. 8.13.2 Panome Bio Business Overview
  76. 8.13.3 Panome Bio Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Panome Bio Plasma Proteomics Service Product Portfolio
  78. 8.13.5 Panome Bio Recent Developments
  79. 8.14 Novogene
  80. 8.14.1 Novogene Company Information
  81. 8.14.2 Novogene Business Overview
  82. 8.14.3 Novogene Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Novogene Plasma Proteomics Service Product Portfolio
  84. 8.14.5 Novogene Recent Developments
  85. 8.15 PTM BIO
  86. 8.15.1 PTM BIO Company Information
  87. 8.15.2 PTM BIO Business Overview
  88. 8.15.3 PTM BIO Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 PTM BIO Plasma Proteomics Service Product Portfolio
  90. 8.15.5 PTM BIO Recent Developments
  91. 8.16 BGI Genomics
  92. 8.16.1 BGI Genomics Company Information
  93. 8.16.2 BGI Genomics Business Overview
  94. 8.16.3 BGI Genomics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BGI Genomics Plasma Proteomics Service Product Portfolio
  96. 8.16.5 BGI Genomics Recent Developments
  97. 8.17 Evotec
  98. 8.17.1 Evotec Company Information
  99. 8.17.2 Evotec Business Overview
  100. 8.17.3 Evotec Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Evotec Plasma Proteomics Service Product Portfolio
  102. 8.17.5 Evotec Recent Developments
  103. 8.18 Metware Biotechnology
  104. 8.18.1 Metware Biotechnology Company Information
  105. 8.18.2 Metware Biotechnology Business Overview
  106. 8.18.3 Metware Biotechnology Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Metware Biotechnology Plasma Proteomics Service Product Portfolio
  108. 8.18.5 Metware Biotechnology Recent Developments
  109. 8.19 MRM Proteomics
  110. 8.19.1 MRM Proteomics Company Information
  111. 8.19.2 MRM Proteomics Business Overview
  112. 8.19.3 MRM Proteomics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 MRM Proteomics Plasma Proteomics Service Product Portfolio
  114. 8.19.5 MRM Proteomics Recent Developments
  115. 8.20 Lc-Bio Technologies
  116. 8.20.1 Lc-Bio Technologies Company Information
  117. 8.20.2 Lc-Bio Technologies Business Overview
  118. 8.20.3 Lc-Bio Technologies Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Lc-Bio Technologies Plasma Proteomics Service Product Portfolio
  120. 8.20.5 Lc-Bio Technologies Recent Developments
  121. 8.21 Eurofins Scientific
  122. 8.21.1 Eurofins Scientific Company Information
  123. 8.21.2 Eurofins Scientific Business Overview
  124. 8.21.3 Eurofins Scientific Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Eurofins Scientific Plasma Proteomics Service Product Portfolio
  126. 8.21.5 Eurofins Scientific Recent Developments
  127. 8.22 MtoZ-Biolabs
  128. 8.22.1 MtoZ-Biolabs Company Information
  129. 8.22.2 MtoZ-Biolabs Business Overview
  130. 8.22.3 MtoZ-Biolabs Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 MtoZ-Biolabs Plasma Proteomics Service Product Portfolio
  132. 8.22.5 MtoZ-Biolabs Recent Developments
  133. 8.23 Creative Proteomics
  134. 8.23.1 Creative Proteomics Company Information
  135. 8.23.2 Creative Proteomics Business Overview
  136. 8.23.3 Creative Proteomics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Creative Proteomics Plasma Proteomics Service Product Portfolio
  138. 8.23.5 Creative Proteomics Recent Developments
  139. 8.24 Macrogen
  140. 8.24.1 Macrogen Company Information
  141. 8.24.2 Macrogen Business Overview
  142. 8.24.3 Macrogen Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Macrogen Plasma Proteomics Service Product Portfolio
  144. 8.24.5 Macrogen Recent Developments
  145. 8.25 TATAA Biocenter
  146. 8.25.1 TATAA Biocenter Company Information
  147. 8.25.2 TATAA Biocenter Business Overview
  148. 8.25.3 TATAA Biocenter Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  149. 8.25.4 TATAA Biocenter Plasma Proteomics Service Product Portfolio
  150. 8.25.5 TATAA Biocenter Recent Developments
  151. 8.26 OmicScouts (Momentum Biotechnologies)
  152. 8.26.1 OmicScouts (Momentum Biotechnologies) Company Information
  153. 8.26.2 OmicScouts (Momentum Biotechnologies) Business Overview
  154. 8.26.3 OmicScouts (Momentum Biotechnologies) Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  155. 8.26.4 OmicScouts (Momentum Biotechnologies) Plasma Proteomics Service Product Portfolio
  156. 8.26.5 OmicScouts (Momentum Biotechnologies) Recent Developments
  157. 8.27 Precision Biomarker Laboratories (PBL)
  158. 8.27.1 Precision Biomarker Laboratories (PBL) Company Information
  159. 8.27.2 Precision Biomarker Laboratories (PBL) Business Overview
  160. 8.27.3 Precision Biomarker Laboratories (PBL) Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Precision Biomarker Laboratories (PBL) Plasma Proteomics Service Product Portfolio
  162. 8.27.5 Precision Biomarker Laboratories (PBL) Recent Developments
  163. 8.28 Shanghai OE Biotech
  164. 8.28.1 Shanghai OE Biotech Company Information
  165. 8.28.2 Shanghai OE Biotech Business Overview
  166. 8.28.3 Shanghai OE Biotech Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Shanghai OE Biotech Plasma Proteomics Service Product Portfolio
  168. 8.28.5 Shanghai OE Biotech Recent Developments
  169. 8.29 RxCelerate
  170. 8.29.1 RxCelerate Company Information
  171. 8.29.2 RxCelerate Business Overview
  172. 8.29.3 RxCelerate Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  173. 8.29.4 RxCelerate Plasma Proteomics Service Product Portfolio
  174. 8.29.5 RxCelerate Recent Developments
  175. 8.30 Proteomics International
  176. 8.30.1 Proteomics International Company Information
  177. 8.30.2 Proteomics International Business Overview
  178. 8.30.3 Proteomics International Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Proteomics International Plasma Proteomics Service Product Portfolio
  180. 8.30.5 Proteomics International Recent Developments
  181. 8.31 Proteome Sciences
  182. 8.31.1 Proteome Sciences Company Information
  183. 8.31.2 Proteome Sciences Business Overview
  184. 8.31.3 Proteome Sciences Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  185. 8.31.4 Proteome Sciences Plasma Proteomics Service Product Portfolio
  186. 8.31.5 Proteome Sciences Recent Developments
  187. 8.32 Westlake Omics
  188. 8.32.1 Westlake Omics Company Information
  189. 8.32.2 Westlake Omics Business Overview
  190. 8.32.3 Westlake Omics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  191. 8.32.4 Westlake Omics Plasma Proteomics Service Product Portfolio
  192. 8.32.5 Westlake Omics Recent Developments
  193. 8.33 Crown Bioscience
  194. 8.33.1 Crown Bioscience Company Information
  195. 8.33.2 Crown Bioscience Business Overview
  196. 8.33.3 Crown Bioscience Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  197. 8.33.4 Crown Bioscience Plasma Proteomics Service Product Portfolio
  198. 8.33.5 Crown Bioscience Recent Developments
  199. 8.34 VProteomics
  200. 8.34.1 VProteomics Company Information
  201. 8.34.2 VProteomics Business Overview
  202. 8.34.3 VProteomics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  203. 8.34.4 VProteomics Plasma Proteomics Service Product Portfolio
  204. 8.34.5 VProteomics Recent Developments
  205. 8.35 Shanghai Majorbio Bio-Pharm
  206. 8.35.1 Shanghai Majorbio Bio-Pharm Company Information
  207. 8.35.2 Shanghai Majorbio Bio-Pharm Business Overview
  208. 8.35.3 Shanghai Majorbio Bio-Pharm Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  209. 8.35.4 Shanghai Majorbio Bio-Pharm Plasma Proteomics Service Product Portfolio
  210. 8.35.5 Shanghai Majorbio Bio-Pharm Recent Developments
  211. 8.36 Applied Biomics
  212. 8.36.1 Applied Biomics Company Information
  213. 8.36.2 Applied Biomics Business Overview
  214. 8.36.3 Applied Biomics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  215. 8.36.4 Applied Biomics Plasma Proteomics Service Product Portfolio
  216. 8.36.5 Applied Biomics Recent Developments
  217. 8.37 Sapient Bioanalytics
  218. 8.37.1 Sapient Bioanalytics Company Information
  219. 8.37.2 Sapient Bioanalytics Business Overview
  220. 8.37.3 Sapient Bioanalytics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  221. 8.37.4 Sapient Bioanalytics Plasma Proteomics Service Product Portfolio
  222. 8.37.5 Sapient Bioanalytics Recent Developments
  223. 8.38 Allumiqs
  224. 8.38.1 Allumiqs Company Information
  225. 8.38.2 Allumiqs Business Overview
  226. 8.38.3 Allumiqs Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  227. 8.38.4 Allumiqs Plasma Proteomics Service Product Portfolio
  228. 8.38.5 Allumiqs Recent Developments
  229. 8.39 MS Bioworks
  230. 8.39.1 MS Bioworks Company Information
  231. 8.39.2 MS Bioworks Business Overview
  232. 8.39.3 MS Bioworks Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  233. 8.39.4 MS Bioworks Plasma Proteomics Service Product Portfolio
  234. 8.39.5 MS Bioworks Recent Developments
  235. 8.40 Shanghai Bioprofile
  236. 8.40.1 Shanghai Bioprofile Company Information
  237. 8.40.2 Shanghai Bioprofile Business Overview
  238. 8.40.3 Shanghai Bioprofile Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  239. 8.40.4 Shanghai Bioprofile Plasma Proteomics Service Product Portfolio
  240. 8.40.5 Shanghai Bioprofile Recent Developments
  241. 8.41 Cosmos Wisdom
  242. 8.42 Olink (Thermo Fisher Scientific)
  243. 8.43 SomaLogic (Illumina)
  244. 8.44 Labcorp
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst